1Gabbay E,Yeow W,Playford D.Pulmonary arterial hypertension (PAH)is an uncommon cause of pulmonary hypertension(PH)in an unselected population:the armadale echocardiography study.Am J Respir Crit Care Med,2008,177:1377-1383.
2Sitbon O,Humbert M,Nunes H,et al.Long-term intravenous epoprostenol infusion in primary pulmonary hypertension:prognostic factors and survival.J Am Coll Cardiol,2002,40:780-788.
3Loewe B,Graefe K,Ufer C,et al.Anxiety and depression in patients with pulmonary hypertension.Psycosom Med,2004,66:394-403.
4Mclaughlin VV,Shillington A,Rich S.Survival in primary pulmonary hypertension:the impact of epoprostenol therapy.Circulation,2002,106:1477-1482.
5Forbes TJ,Garekar S,Amin Z,et al.Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age:a multi-institutional study[J].Catheter Cardiovasc Interv,2007,70(2):276-285.
6Rao PS.Coarctation of the aorta[J].Curt Cardiol Rep,2005,7(6):425-434.
7orbes TJ,Garekar S,Amin Z,et al.Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age:a multi-institutional study[J].Catheter Cardiovasc Interv,2007.70(2):276-285.
8Trivedi KR,Benson LN.Interventional strategies in the management of peripheral pulmonary artery stenosis[J].J Interv Cardiol,2003,16(2):171-188.
9van Gameren M,Witsenburg M,Takkenberg J J,et al.Early complications of stenting in patients with congenital heart disease:a multicentre study[J].Eur Heart J,2006,27(22):2709-2715.
10Ewert P,Schubert S,Peters B,et al.The CP stent--short,long,covered-for the treatment of aortic coarctation,stenosis of pulmonary arteries and caval veins,and Fontan anastomosis in children and adults:an evaluation of 60 stents in 53 patients[J].Heart,2005,91 (7):948-953.
